A detailed history of Binnacle Investments Inc transactions in Amgen Inc stock. As of the latest transaction made, Binnacle Investments Inc holds 208 shares of AMGN stock, worth $71,075. This represents 0.03% of its overall portfolio holdings.

Number of Shares
208
Previous 165 26.06%
Holding current value
$71,075
Previous $46.1 Million 27.41%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$271.18 - $309.22 $11,660 - $13,296
43 Added 26.06%
208 $58.7 Million
Q2 2025

Aug 15, 2025

BUY
$262.28 - $309.85 $5,770 - $6,816
22 Added 15.38%
165 $46.1 Million
Q1 2025

May 13, 2025

BUY
$258.59 - $327.36 $36,978 - $46,812
143 New
143 $44.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Binnacle Investments Inc Portfolio

Follow Binnacle Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Binnacle Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Binnacle Investments Inc with notifications on news.